BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7150243)

  • 1. Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages.
    Lindahl U; Kolset SO; Bøgwald J; Osterud B; Seljelid R
    Biochem J; 1982 Aug; 206(2):231-7. PubMed ID: 7150243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prothrombinase complex of mouse peritoneal macrophages.
    Lindahl U; Pejler G; Bøgwald J; Seljelid R
    Arch Biochem Biophys; 1989 Aug; 273(1):180-8. PubMed ID: 2757391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of human activated factor X-antithrombin complex by an enzyme-linked differential-antibody immunosorbent assay.
    Jesty J; Morrison SA; Harpel PC
    Anal Biochem; 1984 May; 139(1):158-67. PubMed ID: 6742427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y; Aoyagi S; Kusada Y; Miyamoto K
    J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the generation and inhibition of factor Xa. Area under generation curves is independent of enzyme generation rate.
    Jesty J
    J Biol Chem; 1990 Oct; 265(29):17539-44. PubMed ID: 2211647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endotoxin-induced procoagulant of mouse exudate macrophages: a factor-X activator.
    Shands JW
    Blood; 1983 Aug; 62(2):333-40. PubMed ID: 6871467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro.
    Osterud B; Bögwald J; Lindahl U; Seljelid R
    FEBS Lett; 1981 May; 127(1):154-60. PubMed ID: 7250370
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the generation and inhibition of activated coagulation factor X in pure systems and in human plasma.
    Jesty J
    J Biol Chem; 1986 Jul; 261(19):8695-702. PubMed ID: 3722168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Xa inactivation by a heparinized hydrogel.
    Rollason G; Sefton MV
    Thromb Res; 1986 Nov; 44(4):517-25. PubMed ID: 3798412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin and factor Xa enhance the production of interleukin-1.
    Jones A; Geczy CL
    Immunology; 1990 Oct; 71(2):236-41. PubMed ID: 2228024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of decarboxyfactor X by a protein from Russell's viper venom. Purification and partial characterization of activated decarboxyfactor X.
    Lindhout MJ; Kop-Klaassen BH; Hemker HC
    Biochim Biophys Acta; 1978 Apr; 533(2):327-41. PubMed ID: 417734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation protein function. IV. Effect of acetaldehyde upon factor X and factor Xa, the proteins at the gateway to the common coagulation pathway.
    Brecher AS; Koterba AP; Basista MH
    Alcohol; 1996; 13(6):539-45. PubMed ID: 8949947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased heparin sensitivity of cyclohexanedione-modified factor Xa.
    Blaskó G; Machovich R
    Thromb Haemost; 1979 Aug; 42(2):556-63. PubMed ID: 505364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages synthesize factor X and secrete factor X/Xa-containing prothrombinase activity into the surrounding medium.
    Pejler G; Lunderius C; Tomasini-Johansson B
    Thromb Haemost; 2000 Sep; 84(3):429-35. PubMed ID: 11019967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III, heparin cofactor and antifactor Xa in a clinical material.
    Odegård OR; Teien AN
    Thromb Res; 1976 Feb; 8(2):173-8. PubMed ID: 56054
    [No Abstract]   [Full Text] [Related]  

  • 19. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study.
    McGee MP; Wallin R; Wheeler FB; Rothberger H
    Blood; 1989 Oct; 74(5):1583-90. PubMed ID: 2790188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
    Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
    Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.